Kailera Therapeutics, Inc. (KLRA)

15.71 -0.14 (-0.88%) USD  |  NASDAQ  |  Sep 03, 16:00
15.71 0.00 (0.00%) After-Hours: 18:22
More

Kailera Therapeutics Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Cost of Goods Sold (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Cost of Goods Sold Definition

Returns the Cost of Goods Sold (COGS) for the period and date(s) requested in local currency by default.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. --
Sana Biotechnology, Inc. --
Parabilis Medicines, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade